질병모델, 질환모델, 질환모델동물, 질환모델 마우스_Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Product No	Product	Application area
110172	B-ob/ob mice	hyperglycemia and obesity
110170	B-F9 KO mice	hemophilia B
110169	B-F8 KO mice	VII-related coagulopathy disorders
110168	B-Apoe KO mice	cardiovascular disease, lipid metabolism, and Alzheimer’s diseases
110167	B-p53 KO mice	regulate target genes that induce cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism
210509	B-Pink1 KO rats	mitochondrial signaling and Parkinson’s disease
210508	B-Apoe KO rats	diabetes and obesity research, cardiovascular research, atherosclerosis, metabolism research and Alzheimer’s diseases
210506	B-Ldlr KO rats	diabetes and obesity research, cardiovascular research, metabolism research
210505	B-Apoa4 KO rats	regulating appetite and satiety
210507	B-p53 KO rats	cell cycle arrest, apoptosis, senescence, DNA repair and metabolism
112250	B-Rag2/F8 DKO mice	0
112455	B-Il36a/Il36b/Il36g KO mice	0
210510	B-PrP-hAPP-hPS1 rats	0
110875	B-Trp53 mKI(p.Arg172His) mice	0
111259	B-Adipor1 KO mice	0
112567	B-Grn KO mice	0
112357	ROSA26 5xFAD KI mice	0
112036	B-MUP-uPA mice	0
111127	B-Igh-J KO mice(C)	Tumor

바이오사이토젠의 본사는 베이징에 위치하고 있으며, 장쑤성 하이먼, 미국 보스턴, 상하이에 자회사를 보유하고 있습니다. 총 직원수는 약 1200명으로, 100% 자회사인 Eucure Biopharma를 통하여 임상개발을 수행하고 있습니다. 저희에 대해 궁금하신 점이 있다면, 아래의 링크를 클릭하여 무엇이든 문의부탁드립니다.

naver-site-verification: naver8a6b0412e3d2d9dd38f1684b831435ac.html